Assessment of population infection with SARS-CoV-2 in Ontario, Canada, March to June 2020

Shelly Bolotin1,2,3, Vanessa Tran1,3, Shelley L Deeks1,2

  • 1Public Health Ontario, Toronto, Ontario, Canada.

Insights

This study found low SARS-CoV-2 antibody prevalence in Ontario during the first pandemic wave, suggesting public health measures effectively limited virus spread. COVID-19 cases were underestimated by 4.9 times.

Area of Science:

  • Epidemiology
  • Immunology
  • Public Health

Background:

  • Serosurveys are crucial for estimating population infection rates of SARS-CoV-2.
  • Understanding seroprevalence provides insights into the true extent of viral spread beyond reported cases.

Purpose of the Study:

  • To assess the seroprevalence of SARS-CoV-2 antibodies in Ontario, Canada, during the initial phase of the pandemic.
  • To analyze seroprevalence trends across different age groups, sexes, and regions during the first wave.

Main Methods:

  • An observational study utilizing 8,902 residual specimens from the Public Health Ontario laboratory.
  • Testing was conducted across three distinct time periods between March and June 2020.
  • Results were adjusted for antibody test characteristics and compared with PCR-confirmed COVID-19 data.

Main Results:

  • Adjusted seroprevalence ranged from 0.5% in late March-April to 1.5% in late May 2020.
  • Higher seroprevalence was observed in older adults (≥60 years) during March-April and June, and in the 20-59 age group in May.
  • Toronto consistently showed the highest regional seroprevalence across the study periods.

Conclusions:

  • The study indicates a low overall population seroprevalence of SARS-CoV-2 in Ontario during the first pandemic wave.
  • The findings suggest that implemented public health interventions were successful in controlling widespread transmission.
  • PCR-detected COVID-19 cases likely underestimated total SARS-CoV-2 infections by a factor of approximately 4.9.

Related Concept Videos

Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
252
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
224
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.7K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
918
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.7K